Investor Centre

Welcome to the Pacific Edge Investor Centre. Here you will find useful information about being a shareholder of our company.

See the latest news and presentations, keep up to date with our newsletters and shareholder reports, find out when we are holding shareholder meetings and check up on our share price.

Pacific Edge is publicly listed as PEB on both the NZX and ASX.

NZX:PEB

$0.000

Activity (daily)

Value $00,000.000
Volume 00,000
Capitalisation $000,000

Performance (daily)

Open $0.000
Close $0.000
High $0.000
Low $0.000

Data up to date as of 00-00-0000 00:00

Nov 26th, 2024

1H25 Interim Results: Medicare Coverage Catalysts in Focus

Pacific Edge today announces steady financial performance for the six months to the end of September 2024 as it awaits the outcome of several events that have the potential to renew growth in Cxbladder test volume and revenue. [read more]

Nov 6th, 2024

Interim Financial Results to Be Announced 26 November

Pacific Edge today advises that its half year results for the six months ending 30 September 2024 will be released on Tuesday 26 November 2024, prior to 10am.  [read more]

Nov 5th, 2024

Cxbladder Detect+ Now Named Cxbladder Triage Plus

Pacific Edge today announces it has adopted the brand name Cxbladder Triage Plus for its next generation urine-biomarker test. [read more]

Reports and Presentations

For further investor information on Pacific Edge our recent annual reports, investor presentations and investment research reports are available for download below